PHARMACEUTICAL COMPOSITION COMPRISING TIMOLOL
The present invention relates to pharmaceutical composition comprising the beta 1(β1)-receptor blocker timolol and a liquid vehicle comprising a semifluorinated alkane. The pharmaceutical composition of the present invention may be useful for topical administration, for example ophthalmic topical ad...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | HAUPTMEIER, Bernhard EICKHOFF, Kirsten LÖSCHER, Frank KRÖSSER, Sonja STREHL, Diana |
| description | The present invention relates to pharmaceutical composition comprising the beta 1(β1)-receptor blocker timolol and a liquid vehicle comprising a semifluorinated alkane. The pharmaceutical composition of the present invention may be useful for topical administration, for example ophthalmic topical administration and for use in the treatment of glaucoma, increased intraocular pressure, ocular hypertension and/or a symptom associated therewith.
La présente invention concerne une composition pharmaceutique comprenant le timolol bloquant les récepteurs bêta 1 (β1) et un véhicule liquide comprenant un alcane semifluoré. La composition pharmaceutique de la présente invention peut être utile pour une administration topique, par exemple une administration topique ophtalmique et pour une utilisation dans le traitement du glaucome, d'une pression intraoculaire accrue, d'une hypertension oculaire et/ou d'un symptôme associé à celle-ci. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2019185543A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2019185543A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2019185543A13</originalsourceid><addsrcrecordid>eNrjZNAN8HAM8nV0dg0N8XR29FFw9vcN8A_2DPH09wOzgzyDPf3cFUI8ff19_H14GFjTEnOKU3mhNDeDsptriLOHbmpBfnxqcUFicmpeakl8uL-RgaGloYWpqYmxo6ExcaoAh_Qm4g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PHARMACEUTICAL COMPOSITION COMPRISING TIMOLOL</title><source>esp@cenet</source><creator>HAUPTMEIER, Bernhard ; EICKHOFF, Kirsten ; LÖSCHER, Frank ; KRÖSSER, Sonja ; STREHL, Diana</creator><creatorcontrib>HAUPTMEIER, Bernhard ; EICKHOFF, Kirsten ; LÖSCHER, Frank ; KRÖSSER, Sonja ; STREHL, Diana</creatorcontrib><description>The present invention relates to pharmaceutical composition comprising the beta 1(β1)-receptor blocker timolol and a liquid vehicle comprising a semifluorinated alkane. The pharmaceutical composition of the present invention may be useful for topical administration, for example ophthalmic topical administration and for use in the treatment of glaucoma, increased intraocular pressure, ocular hypertension and/or a symptom associated therewith.
La présente invention concerne une composition pharmaceutique comprenant le timolol bloquant les récepteurs bêta 1 (β1) et un véhicule liquide comprenant un alcane semifluoré. La composition pharmaceutique de la présente invention peut être utile pour une administration topique, par exemple une administration topique ophtalmique et pour une utilisation dans le traitement du glaucome, d'une pression intraoculaire accrue, d'une hypertension oculaire et/ou d'un symptôme associé à celle-ci.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20191003&DB=EPODOC&CC=WO&NR=2019185543A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20191003&DB=EPODOC&CC=WO&NR=2019185543A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HAUPTMEIER, Bernhard</creatorcontrib><creatorcontrib>EICKHOFF, Kirsten</creatorcontrib><creatorcontrib>LÖSCHER, Frank</creatorcontrib><creatorcontrib>KRÖSSER, Sonja</creatorcontrib><creatorcontrib>STREHL, Diana</creatorcontrib><title>PHARMACEUTICAL COMPOSITION COMPRISING TIMOLOL</title><description>The present invention relates to pharmaceutical composition comprising the beta 1(β1)-receptor blocker timolol and a liquid vehicle comprising a semifluorinated alkane. The pharmaceutical composition of the present invention may be useful for topical administration, for example ophthalmic topical administration and for use in the treatment of glaucoma, increased intraocular pressure, ocular hypertension and/or a symptom associated therewith.
La présente invention concerne une composition pharmaceutique comprenant le timolol bloquant les récepteurs bêta 1 (β1) et un véhicule liquide comprenant un alcane semifluoré. La composition pharmaceutique de la présente invention peut être utile pour une administration topique, par exemple une administration topique ophtalmique et pour une utilisation dans le traitement du glaucome, d'une pression intraoculaire accrue, d'une hypertension oculaire et/ou d'un symptôme associé à celle-ci.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNAN8HAM8nV0dg0N8XR29FFw9vcN8A_2DPH09wOzgzyDPf3cFUI8ff19_H14GFjTEnOKU3mhNDeDsptriLOHbmpBfnxqcUFicmpeakl8uL-RgaGloYWpqYmxo6ExcaoAh_Qm4g</recordid><startdate>20191003</startdate><enddate>20191003</enddate><creator>HAUPTMEIER, Bernhard</creator><creator>EICKHOFF, Kirsten</creator><creator>LÖSCHER, Frank</creator><creator>KRÖSSER, Sonja</creator><creator>STREHL, Diana</creator><scope>EVB</scope></search><sort><creationdate>20191003</creationdate><title>PHARMACEUTICAL COMPOSITION COMPRISING TIMOLOL</title><author>HAUPTMEIER, Bernhard ; EICKHOFF, Kirsten ; LÖSCHER, Frank ; KRÖSSER, Sonja ; STREHL, Diana</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2019185543A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2019</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>HAUPTMEIER, Bernhard</creatorcontrib><creatorcontrib>EICKHOFF, Kirsten</creatorcontrib><creatorcontrib>LÖSCHER, Frank</creatorcontrib><creatorcontrib>KRÖSSER, Sonja</creatorcontrib><creatorcontrib>STREHL, Diana</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HAUPTMEIER, Bernhard</au><au>EICKHOFF, Kirsten</au><au>LÖSCHER, Frank</au><au>KRÖSSER, Sonja</au><au>STREHL, Diana</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PHARMACEUTICAL COMPOSITION COMPRISING TIMOLOL</title><date>2019-10-03</date><risdate>2019</risdate><abstract>The present invention relates to pharmaceutical composition comprising the beta 1(β1)-receptor blocker timolol and a liquid vehicle comprising a semifluorinated alkane. The pharmaceutical composition of the present invention may be useful for topical administration, for example ophthalmic topical administration and for use in the treatment of glaucoma, increased intraocular pressure, ocular hypertension and/or a symptom associated therewith.
La présente invention concerne une composition pharmaceutique comprenant le timolol bloquant les récepteurs bêta 1 (β1) et un véhicule liquide comprenant un alcane semifluoré. La composition pharmaceutique de la présente invention peut être utile pour une administration topique, par exemple une administration topique ophtalmique et pour une utilisation dans le traitement du glaucome, d'une pression intraoculaire accrue, d'une hypertension oculaire et/ou d'un symptôme associé à celle-ci.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2019185543A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | PHARMACEUTICAL COMPOSITION COMPRISING TIMOLOL |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T22%3A04%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HAUPTMEIER,%20Bernhard&rft.date=2019-10-03&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2019185543A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |